Rights and permissions
About this article
Cite this article
Paclitaxel, doxorubicin regimen better for breast cancer. Inpharma Wkly. 1474, 9–10 (2005). https://doi.org/10.2165/00128413-200514740-00022
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200514740-00022